Custom service

Dipeptide Synthesis

Synthesize dipeptides at research or bulk scale with defined protecting groups

Turnaround: 2–4 weeksTypical scale: 0.1 mg – 10 g per sequenceChemistry options: protecting-group-flexible synthesis; racemization-controlled coupling; salt and free-base forms

Dipeptide Synthesis supports programmes that synthesize dipeptides at research or bulk scale with defined protecting groups. In a typical engagement we plan the protecting-group-flexible synthesis route first, confirm compatibility with racemization-controlled coupling, and release dipeptide with purity and stereochemistry QC on a 2–4 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep protecting-group-flexible synthesis as the primary option and hold racemization-controlled coupling in reserve, so that scale-up never depends on an unproven step.

Dipeptide intermediates for drug synthesis

Sweetener and nutraceutical ingredient candidates

Food-grade production certifications

Sequences where a recombinant expression route is objectively cheaper and faster

Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.

Service Highlights

  • Protecting-group-flexible synthesis as the default route, with racemization-controlled coupling held as a proven fallback
  • Salt and free-base forms worked into the design where the application requires it
  • Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
  • Analytical confirmation of every intermediate before the final release
  • Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
  • Dipeptide with purity and stereochemistry QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence analysis

    Dipeptide Synthesis is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.

  2. Route selection

    Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.

  3. Assembly

    The chain is built with protecting-group-flexible synthesis applied where the sequence demands it, with double-coupling at hazard sites.

  4. Cleavage & crude QC

    Crude material is characterized so purification targets are set on data, not hope.

  5. Purification

    RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.

  6. Release

    Dipeptide with purity and stereochemistry QC is documented with the full analytical package and released.

Specifications & timeline

Turnaround
2–4 weeks
Typical scale
0.1 mg – 10 g per sequence
Chemistry options
protecting-group-flexible synthesis; racemization-controlled coupling; salt and free-base forms
Deliverable
Dipeptide with purity and stereochemistry QC
QC package
HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
Shipping
Ambient with desiccant; blue ice for modified or sensitive peptides

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.